Dehaier to Attend Sleep Apnea Seminar in Qingdao
December 20 2013 - 8:00AM
Dehaier Medical Systems Ltd. (Nasdaq:DHRM)
("Dehaier" or the "Company"), an emerging leader in the
development, assembly, marketing and sale of medical devices and
homecare medical products in China, announced it will attend the
Sleep Disorders New Progress seminar in Qingdao on December 21,
2013. Professors from Beijing Tongren Hospital, Jiangsu People's
Hospital, Beijing Peking Union Medical College Hospital and
Shandong Qilu Hospital will attend this seminar, at which
significant studies and scientific updates related to sleep apnea
are expected to be presented. Dehaier will display and demonstrate
the Sleep Respiratory Diagnosis System to the audiences.
Rayna Dong, Dehaier Marketing Director, said, "Our system can
successfully treat most common sleep disorders. Our innovative,
state-of-the-art system allows patients to diagnose the reasons for
their sleep disorders so that they can seek appropriate care. The
system also automatically captures raw data while patients sleep
and monitors and analyzes such data to help select suitable CPAP
devices for treatment and evaluation. Introduction of our new
product at the Qingdao seminar will build a solid foundation for
the next stage to fully enter the market. This seminar provides us
a platform to communicate with industry leaders and stay abreast of
industry developments. Our new System is one of our major strategic
foci over the near term, and we expect it will play a major role in
our growth in the long run."
About Dehaier Medical Systems
Ltd.
Dehaier is an emerging leader in the development, assembly,
marketing and sale of medical products, including respiratory and
oxygen homecare medical products. The company develops and
assembles its own branded medical devices and homecare medical
products from third-party components. The company also distributes
products designed and manufactured by other companies, including
medical devices from IMD (Italy), Welch Allyn (USA), HEYER
(Germany), Timesco (UK), eVent Medical (US) and JMS (Japan).
Dehaier's technology is based on six patents, ten software
copyrights and proprietary technology. More information may be
found at http://www.dehaier.com.cn
Forward-looking Statements
This news release contains forward-looking statements as defined
by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events, government approvals
or performance, and underlying assumptions and other statements
that are other than statements of historical facts, including in
particular any implications regarding potential results of
attending the 2013 Qingdao Sleep Disorders New Progress Seminar.
These statements are subject to uncertainties and risks including,
but not limited to, product and service demand and acceptance,
changes in technology, economic conditions, the impact of
competition and pricing, government regulation, future developments
in payment for and demand for medical equipment and services,
implementation of and performance under the joint venture agreement
by all parties, and other risks contained in reports filed by the
company with the Securities and Exchange Commission. All such
forward-looking statements, whether written or oral, and whether
made by or on behalf of the company, are expressly qualified by the
cautionary statements and any other cautionary statements which may
accompany the forward-looking statements. In addition, the company
disclaims any obligation to update any forward-looking statements
to reflect events or circumstances after the date hereof.
CONTACT: Dehaier Medical Systems Limited
Surie Liu
+86 10-5166-0080
lius@dehaier.com.cn
Dehaier Medical Systems Limited
Tina He
+86 10-5166-0080
hexw@dehaier.com.cn
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jul 2023 to Jul 2024